Molecular Therapy Family's Impact Factor Increased 44 Percent in 2020

Impact factor scores for the Molecular Therapy family of journals, the official journals of the American Society of Gene & Cell Therapy (ASGCT), rose by a collective average of 44 percent in 2020.

Impact factors, which measure the frequency with which an average article has been cited in a journal, rank research titles against one another to determine leading journals around the world.

Overall growth in the Molecular Therapy family of journals is as follows:

• Molecular Therapy: 11.454 (+27 percent)
  • Ranked 11/140 in the category of medicine, research, and experimental and 6/159 in the category of biotechnology and applied microbiology
  • Received 24,333 citations in 2020
• Molecular Therapy-Nucleic Acids: 8.886 (+26 percent)
  • Ranked 13/140 in medicine, research, and experimental
  • Received 8,812 citations in 2020
• Molecular Therapy-Oncolytics: 7.200 (+75 percent)
  • Ranked 20/140 in medicine, research, and experimental and 44/242 in oncology
  • Received 1,582 citations in 2020
  • Highest percent increase across more than 50 journals from publisher Cell Press
• Molecular Therapy-Methods & Clinical Development: 6.698 (+48 percent)
  • Ranked 25/140 in medicine, research, and experimental
  • Received 3,268 citations in 2020

Related Articles